Zeltiq Announces Proposed Public Offering of Common Stock

PLEASANTON, Calif., Nov. 5, 2013 (GLOBE NEWSWIRE) -- ZELTIQ®, (Nasdaq:ZLTQ) a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, announced today the commencement of an underwritten public offering of 4,500,000 shares of its common stock, all of which are being offered by selling stockholders. The selling stockholders also expect to grant the underwriters a 30-day option to purchase up to 675,000 additional shares. Goldman Sachs & Co. and J.P. Morgan Securities LLC are acting as joint book-running managers for the offering, and Canaccord Genuity Inc. and William Blair & Company L.L.C. are acting as co-managers for the offering.

Help employers find you! Check out all the jobs and post your resume.